Chile - Renin-Angiotensin System Medicine Use
Since 2014, Chile Renin-Angiotensin System Medicine Use decreased by 3.5% year on year. In 2019, the country was number 6 among other countries in Renin-Angiotensin System Medicine Use with 231 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Chile is overtaken by Slovenia, which was number 5 with 249.4 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Italy at 221.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Hungary ranked the highest with 369.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, a growth of 0.6% versus 2018. Germany, Czech Republic and Finland respectively ranked number 2, 3 and 4 in this ranking. Austria recorded the best 5 years average growth at +10.2% per year, while Chile was the worst growing country at -3.5% per year.
Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
---|---|
2019 | 231.00 |
2018 | 161.30 |
2017 | 173.60 |
2016 | 215.60 |
2015 | 228.10 |
How does Chile rank in Renin-Angiotensin System Medicine Use?
# | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Hungary
|
370 | 2019 | +0.6 % | +0.6 % | View data | |
2 |
#2
Germany
|
358 | 2019 | +3.4 % | +1.7 % | View data | |
5 |
#5
Slovenia
|
249 | 2019 | +0.8 % | -0.9 % | View data | |
6 |
#6
Chile
|
231 | 2019 | +43.2 % | -3.5 % | View data | |
7 |
#7
Italy
|
222 | 2019 | +0.5 % | -0.0 % | View data |